Cytokines regulate cysteine cathepsins during TLR responses

Cellular Immunology

Volumn 267, Issue 1, 2011, Pages 56-66

  Creasy, Blaine M ^a,b   McCoy, Kathleen L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Cathepsins; Endosomal proteases; Inflammatory response; Macrophage activation; Pattern recognition receptors; Signal transduction; Toll like receptors

Indexed keywords

BETA INTERFERON; CATHEPSIN; CATHEPSIN B; CATHEPSIN L; CATHEPSIN S; CYTOKINE; INTERLEUKIN 1BETA; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; NEUTRALIZING ANTIBODY; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RESPONSE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME DEGRADATION; FEMALE; IMMUNOREGULATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CATHEPSINS; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; INTERFERON-BETA; INTERLEUKIN-1BETA; LIGANDS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED C57BL; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78651095760     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2010.11.004     Document Type: Article

References (48)

1. Trinchieri G., Sher A. Cooperation of toll-like receptor signals in innate immune defense. Nat. Rev. Immunol. 2007, 7:179-190.
2. Jones B.W., Heldwein K.A., Means T.K., Saukkonen J.J., J Fenton M. Differential roles of toll-like receptors in the elicitation of proinflammatory responses by macrophages. Ann. Rheum. Dis. 2001, 60(Suppl. 3):iii6-iii12.
3. Jones B.W., Means T.K., Heldwein K.A., Keen M.A., Hill P.J., Belisle J.T., Fenton M.J. Different toll-like receptor agonists induce distinct macrophage responses. J. Leukoc. Biol. 2001, 69:1036-1044.
4. Hirschfeld M., Weis J.J., Toshchakov V., Salkowski C.A., Cody M.J., Ward D.C., Qureshi N., Michalek S.M., Vogel S.N. Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect. Immun. 2001, 69:1477-1482.
5. Bjorkbacka H., Fitzgerald K.A., Huet F., Li X., Gregory J.A., Lee M.A., Ordija C.M., Dowley N.E., Golenbock D.T., Freeman M.W. The induction of macrophage gene expression by LPS predominantly utilizes MyD88-independent signaling cascades. Physiol. Genomics 2004, 19:319-330.
6. Takeda K., Akira S. TLR signaling pathways. Semin. Immunol. 2004, 16:3-9.
7. Karin M., Lawrence T., Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006, 124:823-835.
8. Gribar S.C., Anand R.J., Sodhi C.P., Hackam D.J. The role of epithelial Toll-like receptor signaling in the pathogenesis of intestinal inflammation. J. Leukoc. Biol. 2008, 83:493-498.
9. Tobias P.S., Curtiss L.K. Toll-like receptors in atherosclerosis. Biochem. Soc. Trans. 2007, 35:1453-1455.
10. Huang Q., Ma Y., Adebayo A., Pope R.M. Increased macrophage activation mediated through toll-like receptors in rheumatoid arthritis. Arthritis Rheum. 2007, 5:2192-2201.
11. Huang B., Zhao J., Unkeless J.C., Feng Z.H., Xiong H. TLR signaling by tumor and immune cells: a double-edged sword. Oncogene 2008, 27:218-224.
12. Berdowska I. Cysteine proteases as disease markers. Clin. Chim. Acta 2004, 342:41-69.
13. Honey K., Rudensky A.Y. Lysosomal cysteine proteases regulate antigen presentation. Nat. Rev. Immunol. 2003, 3:472-482.
14. Joyce J.A., Baruch A., Chehade K., Meyer-Morse N., Giraudo E., Tsai F.Y., Greenbaum D.C., Hager J.H., Bogyo M., Hanahan D. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 2004, 5:443-453.
15. Gocheva V., Zeng W., Ke D., Klimstra D., Reinheckel T., Peters C., Hanahan D., Joyce J.A. Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev. 2006, 20:543-556.
16. Murray P., Wang L., Onufryk C., Tepper R., Young R. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J. Immunol. 1997, 158:315-321.
17. Creasy B.M., Hartmann C.B., Higgins White F.K., McCoy K.L. New assay using fluorogenic substrates and immunofluorescence staining to measure cysteine cathepsin activity in live cell subpopulations. Cytometry Part A 2007, 71:114-123.
18. Beum P.V., Lindorfer M.A., Hall B.E., George T.C., Frost K., Morrissey P.J., Taylor R.P. Quantitative analysis of protein co-localization on B cells opsonized with rituximab and complement using the ImageStream multispectral imaging flow cytometer. J. Immunol. Methods 2006, 317:90-99.
19. Harrison M.T., Hartmann C.B., McCoy K.L. Impact of in vitro gallium arsenide exposure on macrophages. Toxicol. Appl. Pharmacol. 2003, 186:18-27.
20. Takeuchi O., Takeda K., Hoshino K., Adachi O., Ogawa T., Akira S. Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades. Int. Immunol. 2000, 12:113-117.
21. Lennon-Dumenil A.M., Bakker A.H., Maehr R., Fiebiger E., Overkleeft H.S., Rosemblatt M., Ploegh H.L., Lagaudriere-Gesbert C. Analysis of protease activity in live antigen-presenting cells shows regulation of the phagosomal proteolytic contents during dendritic cell activation. J. Exp. Med. 2002, 196:529-540.
22. Lautwein A., Burster T., Lennon-Dumenil A.M., Overkleeft H.S., Weber E., Kalbacher H., Driessen C. Inflammatory stimuli recruit cathepsin activity to late endosomal compartments in human dendritic cells. Eur. J. Immunol. 2002, 32:3348-3357.
23. Watari M., Watari H., Nachamkin I., Strauss J.F. Lipopolysaccharide induces expression of genes encoding pro-inflammatory cytokines and the elastin-degrading enzyme, cathepsin S, in human cervical smooth-muscle cells. J. Soc. Gynecol. Investig. 2000, 7:190-198.
24. Trivedi S., Greidinger E.L. Endosomal toll-like receptors in autoimmunity: mechanisms for clinical diversity. Therapy 2009, 6:433-442.
25. Matsumoto F., Saitoh S., Fukui R., Kobayashi T., Tanimura N., Konno K., Kusumoto Y., Akashi-Takamura S., Miyake K. Cathepsins are required for toll-like receptor 9 responses. Biochem. Biophys. Res. Commun. 2008, 367:693-699.
26. Park B., Brinkmann M.M., Spooner E., Lee C.C., Kim Y.-M., Ploegh H.L. Proteolytic cleavage in an endolysosomal compartment is required for toll-like receptor 9 activation. Nat. Immunol. 2008, 9:1407-1414.
27. O'Neill L.A. Toll-like receptor signal transduction and the tailoring of innate immunity: a role for Mal?. Trends Immunol. 2002, 23:296-300.
28. O'Neill L.A. How toll-like receptors signal: what we know and what we don't know. Curr. Opin. Immunol. 2006, 18:3-9.
29. Lemaire R., Huet G., Zerimech F., Grard G., Fontaine C., Duquesnoy B., Flipo R.M. Selective induction of the secretion of cathepsins B and L by cytokines in synovial fibroblast-like cells. Br. J. Rheumatol. 1997, 36:735-743.
30. Lah T.T., Hawley M., Rock R.L., Goldberg A.L. Gamma-interferon causes a selective induction of the lysosomal proteases, cathepsins B and L, in macrophages. FEBS Lett. 1995, 363:85-89.
31. Kitamura H., Kamon H., Sawa S., Park S.J., Katunuma N., Ishihara K., Murakami M., Hirano T. IL-6-STAT3 controls intracellular MHC class II alphabeta dimer level through cathepsin S activity in dendritic cells. Immunity 2005, 23:491-502.
32. Chae H.J., Ha K.C., Lee G.Y., Yang S.K., Yun K.J., Kim E.C., Kim S.H., Chae S.W., Kim H.R. Interleukin-6 and cyclic AMP stimulate release of cathepsin B in human osteoblasts. Immunopharmacol. Immunotoxicol. 2007, 29:155-172.
33. Fiebiger E., Meraner P., Weber E., Fang I.F., Stingl G., Ploegh H., Maurer D. Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells. J. Exp. Med. 2001, 193:881-892.
34. Zughaier S., Zimmer S., Datta A., Carlson R., Stephens D. Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins. Infect. Immun. 2005, 73:2940-2950.
35. Honey K., Duff M., Beers C., Brissette W.H., Elliott E.A., Peters C., Maric M., Cresswell P., Rudensky A. Cathepsin S regulates the expression of cathepsin L and the turnover of gamma-interferon-inducible lysosomal thiol reductase in B lymphocytes. J. Biol. Chem. 2001, 276:22573-22578.
36. Keyszer G., Redlich A., Haupl T., Zacher J., Sparmann M., Engethum U., Gay S., Burmester G.R. Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis: a parallel investigation by semiquantitative reverse transcriptase-polymerase chain reaction and immunohistochemistry. Arthritis Rheum. 1998, 41:1378-1387.
37. Liu J., Sukhova G.K., Sun J.S., Xu W.H., Libby P., Shi G.P. Lysosomal cysteine proteases in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1359-1366.
38. Kopitar-Jerala N. The role of cystatins in cells of the immune system. FEBS Lett. 2006, 580:6295-6301.
39. Boes M., van der Wel N., Peperzak V., Kim Y.M., Peters P.J., Ploegh H. In vivo control of endosomal architecture by class II-associated invariant chain and cathepsin S. Eur. J. Immunol. 2005, 35:2552-2562.
40. Pierre P., Mellman I. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 1998, 93:1135-1145.
41. Zavasnik-Bergant T., Repnik U., Schweiger A., Romih R., Jeras M., Turk V., Kos J. Differentiation- and maturation-dependent content, localization, and secretion of cystatin C in human dendritic cells. J. Leukoc. Biol. 2005, 78:122-134.
42. El Sukkari D., Wilson N.S., Hakansson K., Steptoe R.J., Grubb A., Shortman K., Villadangos J.A. The protease inhibitor cystatin C is differentially expressed among dendritic cell populations, but does not control antigen presentation. J. Immunol. 2003, 171:5003-5011.
43. Trombetta E.S., Ebersold M., Garrett W., Pypaert M., Mellman I. Activation of lysosomal function during dendritic cell maturation. Science 2003, 299:1400-1403.
44. Vyas J.M., Kim Y.-M., Artavanis-Tsakona K., Love C.J., Van der Veen A.G., Ploegh H. Tubulation of class II MHC compartments is microtubule dependent and involves multiple endolysosomal membrane proteins in primary dendritic cells. J. Immunol. 2007, 178:7199-7210.
45. Kleijmeer M., Ramm G., Schuurhuis D., Griffith J., Rescigno M., Ricciardi-Castagnoli P., Rudensky A.Y., Ossendorp F., Melief C.J., Stoorvogel W., Geuze H.J. Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells. J. Cell Biol. 2001, 155:53-63.
46. Storm van's Gravesande K., Layne M.D., Ye Q., Le L., Baron R.M., Perrella M.A., Santambrogio L., Silverman E.S., Riese R.J. IFN regulatory factor-1 regulates IFN-gamma-dependent cathepsin S expression. J. Immunol. 2002, 168:4488-4494.
47. Remoli M.E., Gafa V., Giacomini E., Severa M., Lande R., Coccia E.M. IFN-β modulates the response to TLR stimulation in human DC: involvement of IFN regulatory factor-1(IRF-1) in IL-27 gene expression. Eur. J. Immunol. 2007, 37:3499-3508.
48. Theofilopoulos A.N., Baccala R., Beutler B., Kono D.H. Type I interferons (α/β) in immunity and autoimmunity. Annu. Rev. Immunol. 2005, 23:307-336.